Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dal-VESSEL: Dalcetrapib in CHD
NCT00655538Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of dalcetrapib in coronary heart disease (CHD), sponsored by Roche. Started Feb 2008; status: completed.
02
Drugs
dalcetrapib
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00655538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655538.